InvestorsHub Logo
Post# of 252302
Next 10
Followers 14
Posts 3822
Boards Moderated 1
Alias Born 07/07/2002

Re: DewDiligence post# 197612

Monday, 11/23/2015 3:32:42 PM

Monday, November 23, 2015 3:32:42 PM

Post# of 252302
CHRS has Humira and Enbrel FoBs in the pipeline in addition to Neulasta FoB. What fraction of their value derives from Neulasta FoB expectations?

http://investors.coherus.com/Mobile.view?c=253655&d=4&v=100

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.